| 摘要 |
The present invention relates, in general, to Pompe disease and, in particular, to a methods of treating Pompe disease and to compounds/constructs suitable for use in such methods. The methods involve the administration of an adenoassociated viral vector in the context of enzyme replacement therapy. |
